Management of convulsive status epilepticus: recent updates
encephalitis · 10.04.2023 · 3 (2) · 39-43
DOI: 10.47936/encephalitis.2022.00087 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift encephalitis, erschienen am 10.04.2023. Verfasst von Jung-Ick Byun. Beteiligte Einrichtung: Department of Neurology, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine, Seoul, Korea. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Convulsive status epilepticus (SE) is a medical emergency associated with high morbidity and mortality. Recently, clinical trials and meta-analyses investigating medical treatment of SE have been published. Benzodiazepine is well known as the first-line treatment for SE. Recent evidence suggests the equivalence of intravenous fosphenytoin, valproate, and levetiracetam for treatment of established SE. There is lack of evidence regarding treatment for refractory SE. Intravenous midazolam is commonly used, and recent evidence supports the use of ketamine. Additional studies are needed to improve the management of convulsive SE.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine, Seoul, Korea.
ORCID-Profile: Jung-Ick Byun
Zitieren
APA
Byun, J. I. (2023). Management of convulsive status epilepticus: recent updates. encephalitis, 3(2), 39-43. https://doi.org/10.47936/encephalitis.2022.00087
Vancouver
Byun JI. Management of convulsive status epilepticus: recent updates. encephalitis. 2023;3(2):39-43. doi:10.47936/encephalitis.2022.00087
BibTeX
@article{Byun2023,
author = {Byun, Jung-Ick},
title = {Management of convulsive status epilepticus: recent updates},
journal = {encephalitis},
year = {2023},
volume = {3},
number = {2},
pages = {39--43},
doi = {10.47936/encephalitis.2022.00087}
}
EUVIMED